This newslink doesn't exist or it was removed.
Go to Homempage.
MarketWatch USA Business December 14, 2023
In the new announcement Thursday morning, Moderna said that updated results after three years show that the combination regimen of the Moderna treatment and Keytruda continued to offer improvements in survival rates over Keytruda alone. Investors have been enthusiastic about the... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
The Daily Beast USA World January 02, 2023
The novel coronavirus could help us cure cancer. Well, certain cancers.The gave the pharmaceutical industry the push it needed to finally finish developing so that companies such as could use the tech for its COVID vaccines.Now the pharmaceutical industry is using the same mRNA... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine makers BioNTech | ABC News
What is metastatic breast cancer? | WPLG Local 10
The Boston Globe USA Nation September 22, 2022
Soy mexicana-estadounidense. Chicana. Latina. Y no hablo español. En San Antonio, donde crecí, eso era común entre mis compañeros latinos, tanto si eran de primera generación como si su familia había vivido allí desde la época en que. Pero comprendí que, para algunas... + más
Latin Grammy Awards 2022: See the list of nominees | CNN
Rockstar confirms Grand Theft Auto VI leak came from “network intrusion” | Ars Technica
Orlando Sentinel USA Nation November 09, 2022
Los puertorriqueños ahora tienen la opción de recibir atención de Orlando Health sin salir de la isla. Orlando Health adquirió el mes pasado Sabanera Health Dorado, un hospital de cuidados intensivos en el norte de Puerto Rico administrado por una cadena llamada Doctors’... + más
Opinion | NBC News
Orlando Health care available in Puerto Rico through hospital partnership | Orlando Sentinel
The Boston Globe USA Business October 13, 2022
COVID-19 vaccine maker Moderna’s stock rose the most in two months after Merck & Co. said it would exercise an option to work in partnership with the biotech on a messenger RNA cancer vaccine.Moderna will receive $250 million from Merck in exchange for joint development and... + más
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients | CNBC
About iurex | Privacy Policy | Disclaimer |